Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

febuxostat Oral Tablet [Uloric]

 
National Institutes of Health

Related topics

Related topics

2 relations
Oral Tablet

Narrower (1)

febuxostat 80 MG Oral Tablet [Uloric]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Febuxostat: A Review of Its Use in the Treatment of Hyperuricaemia in Patients with Gout
Febuxostat (Adenuric®, Uloric®, Feburic®) is an orally-active, potent, non-purine, selective xanthine oxidase inhibitor. In the… Expand
  • table 1
  • table 2
  • table 3
  • figure 2
  • table 4
2014
2014
Inhibition of xanthine oxidase by the aldehyde oxidase inhibitor raloxifene: implications for identifying molybdopterin nitrite reductases.
Sources of nitric oxide alternative to nitric oxide synthases are gaining significant traction as crucial mediators of vessel… Expand
  • figure 1
  • figure 2
  • figure 3
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE